For the quarter ended September 2025, HCA Healthcare (HCA) reported revenue of $19.16 billion, up 9.6% over the same period last year. EPS came in at $6.96, compared to $5.05 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $18.5 billion, representing a surprise of +3.55%. The company delivered an EPS surprise of +23.19%, with the consensus EPS estimate being $5.65.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how HCA performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue per Equivalent Admission: $18,446.00 compared to the $17,966.71 average estimate based on five analysts.
- Equivalent Admissions: 1.04 billion versus 1.03 billion estimated by five analysts on average.
- Admissions: 577.8 million versus 575.37 million estimated by three analysts on average.
- Patient Days: 2,692.51 Days compared to the 2,718.89 Days average estimate based on two analysts.
- Average Length of Stay: 5 versus 5 estimated by two analysts on average.
- Number of hospitals: 191 versus 191 estimated by two analysts on average.
- Inpatient Revenue per Admission: $19,908.00 compared to the $19,196.22 average estimate based on two analysts.
- Equivalent Patient Days: 4.84 million versus the two-analyst average estimate of 4.86 million.
- Licensed Beds at End of Period: 50,577 versus the two-analyst average estimate of 50,346.
- Number of freestanding outpatient surgery centers: 123 compared to the 124 average estimate based on two analysts.
View all Key Company Metrics for HCA here>>>
Shares of HCA have returned +6.1% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HCA Healthcare, Inc. (HCA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
